Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemiaFary Diop, Gianluca Gaïdano, Clive Jabangwe et al.|Haematologica|2019Cited by 87
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Antonella Zucchetto, Federico Pozzo et al.|Blood|2020Cited by 62
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL studyMassimo Gentile, Valter Gattei, Fortunato Morabito et al.|Leukemia|2020Cited by 24
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Valter Gattei, Annalisa Gaglio et al.|Leukemia|2024Cited by 6
Mutations of the <i>Exportin 1 (XPO1)</i> Gene Predict Shorter Time to First Treatment in 1092 Early Stage Chronic Lymphocytic Leukemia Patients. Α Training/Validation StudyRiccardo Moia, Valter Gattei, Chiara Favini et al.|Blood|2020Cited by 1